Role and regulation of ferritin H in rotenone-mediated mitochondrial oxidative stress

Free Radical Biology and Medicine

Volumn 44, Issue 9, 2008, Pages 1762-1771

  MacKenzie, Elizabeth L ^a   Ray, Paul D ^a   Tsuji, Yoshiaki ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Ferritin; Free radicals; Iron; Mitochondria; Oxidative stress; Rotenone

Indexed keywords

ACETYLCYSTEINE; FERRITIN; LIPOCORTIN 5; LUCIFERASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; ROTENONE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR JUND; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CELL LINE; CELL PROTECTION; CHROMATIN IMMUNOPRECIPITATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FIBROBLAST; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPORTER GENE; TRANSCRIPTION INITIATION;

ANIMALS; ANTIOXIDANTS; APOFERRITINS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; NF-E2-RELATED FACTOR 2; NIH 3T3 CELLS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS; ROTENONE; UNCOUPLING AGENTS;

EID: 41549133538     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.01.031     Document Type: Article

References (45)

1. Papanikolaou G., and Pantopoulos K. Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 202 (2005) 199-211
2. MacKenzie E.L., Iwasaki K., and Tsuji Y. Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid. Redox Signaling 10 (2008) 997-1030
3. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic. Biol. Med. 23 (1997) 783-792
4. Bossy-Wetzel E., Schwarzenbacher R., and Lipton S.A. Molecular pathways to neurodegeneration. Nat. Med. 10 Suppl. (2004) S2-S9
5. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 10 Suppl. (2004) S18-S25
6. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic. Biol. Med. 20 (1996) 553-566
7. Theil E.C., Matzapetakis M., and Liu X. Ferritins: iron/oxygen biominerals in protein nanocages. J. Biol. Inorg. Chem. 11 (2006) 803-810
8. Santambrogio P., Levi S., Cozzi A., Corsi B., and Arosio P. Evidence that the specificity of iron incorporation into homopolymers of human ferritin L- and H-chains is conferred by the nucleation and ferroxidase centres. Biochem. J. 314 (1996) 139-144
9. Cozzi A., Corsi B., Levi S., Santambrogio P., Biasiotto G., and Arosio P. Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin. Blood 103 (2004) 2377-2383
10. Arosio P., and Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic. Biol. Med. 33 (2002) 457-463
11. Hentze M.W., Muckenthaler M.U., and Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117 (2004) 285-297
12. Torti S.V., Kwak E.L., Miller S.C., Miller L.L., Ringold G.M., Myambo K.B., Young A.P., and Torti F.M. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J. Biol. Chem. 263 (1988) 12638-12644
13. Pham C.G., Bubici C., Zazzeroni F., Papa S., Jones J., Alvarez K., Jayawardena S., De Smaele E., Cong R., Beaumont C., Torti F.M., Torti S.V., and Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119 (2004) 529-542
14. Iwasaki K., Mackenzie E.L., Hailemariam K., Sakamoto K., and Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Mol. Cell. Biol. 26 (2006) 2845-2856
15. Tsuji Y., Ayaki H., Whitman S.P., Morrow C.S., Torti S.V., and Torti F.M. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol. Cell. Biol. 20 (2000) 5818-5827
16. Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene 24 (2005) 7567-7578
17. Hintze K.J., and Theil E.C. DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15048-15052
18. Nguyen T., Sherratt P.J., and Pickett C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 233-260
19. Przedborski S., and Ischiropoulos H. Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease. Antioxid. Redox Signal. 7 (2005) 685-693
20. Kaur D., Yantiri F., Rajagopalan S., Kumar J., Mo J.Q., Boonplueang R., Viswanath V., Jacobs R., Yang L., Beal M.F., DiMonte D., Volitaskis I., Ellerby L., Cherny R.A., Bush A.I., and Andersen J.K. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37 (2003) 899-909
21. Berg D., Gerlach M., Youdim M.B., Double K.L., Zecca L., Riederer P., and Becker G. Brain iron pathways and their relevance to Parkinson's disease. J. Neurochem. 79 (2001) 225-236
22. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
23. Tsuji Y., Akebi N., Lam T.K., Nakabeppu Y., Torti S.V., and Torti F.M. FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression. Mol. Cell. Biol. 15 (1995) 5152-5164
24. Kushnareva Y., Murphy A.N., and Andreyev A. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem. J. 368 (2002) 545-553
25. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., and Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13 (1999) 76-86
26. Theil E.C. Integrating iron and oxygen/antioxidant signals via a combinatorial array of DNA (antioxidant response elements) and mRNA (iron responsive elements) sequences. J. Inorg. Biochem. 100 (2006) 2074-2078
27. Epsztejn S., Glickstein H., Picard V., Slotki I.N., Breuer W., Beaumont C., Cabantchik, and Z. I. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94 (1999) 3593-3603
28. Orino K., Lehman L., Tsuji Y., Ayaki H., Torti S.V., and Torti F.M. Ferritin and the response to oxidative stress. Biochem. J. 357 (2001) 241-247
29. Faucheux B.A., Martin M.E., Beaumont C., Hunot S., Hauw J.J., Agid Y., and Hirsch E.C. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J. Neurochem. 83 (2002) 320-330
30. Thompson K., Menzies S., Muckenthaler M., Torti F.M., Wood T., Torti S.V., Hentze M.W., Beard J., and Connor J. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J. Neurosci. Res. 71 (2003) 46-63
31. Liu R.M., Shi M.M., Giulivi C., and Forman H.J. Quinones increase gamma-glutamyl transpeptidase expression by multiple mechanisms in rat lung epithelial cells. Am. J. Physiol. 274 (1998) L330-L336
32. Tretter L., Sipos I., and Adam-Vizi V. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem. Res. 29 (2004) 569-577
33. Grunblatt E., Mandel S., Maor G., and Youdim M.B. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine. J. Neurochem. 78 (2001) 1-12
34. Thompson R.J., Buttigieg J., Zhang M., and Nurse C.A. A rotenone-sensitive site and H2O2 are key components of hypoxia-sensing in neonatal rat adrenomedullary chromaffin cells. Neuroscience 145 (2007) 130-141
35. Lluis J.M., Buricchi F., Chiarugi P., Morales A., and Fernandez-Checa J.C. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res. 67 (2007) 7368-7377
36. Witting P.K., Rayner B.S., Wu B.J., Ellis N.A., and Stocker R. Hydrogen peroxide promotes endothelial dysfunction by stimulating multiple sources of superoxide anion radical production and decreasing nitric oxide bioavailability. Cell. Physiol. Biochem. 20 (2007) 255-268
37. Shih A.Y., Imbeault S., Barakauskas V., Erb H., Jiang L., Li P., and Murphy T.H. Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J. Biol. Chem. 280 (2005) 22925-22936
38. Calkins M.J., Jakel R.J., Johnson D.A., Chan K., Kan Y.W., and Johnson J.A. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 244-249
39. Tsuji Y., Kwak E., Saika T., Torti S.V., and Torti F.M. Preferential repression of the H subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts. J. Biol. Chem. 268 (1993) 7270-7275
40. Kaur D., Rajagopalan S., Chinta S., Kumar J., Di Monte D., Cherny R.A., and Andersen J.K. Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration. Brain Res. 1140 (2007) 188-194
41. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G.P., Hebenstreit G., and Youdim M.B. Increased iron(III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural Transm. 74 (1988) 199-205
42. Moos T., and Morgan E.H. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann. N.Y. Acad. Sci. 1012 (2004) 14-26
43. Sangchot P., Sharma S., Chetsawang B., Porter J., Govitrapong P., and Ebadi M. Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture. Dev. Neurosci. 24 (2002) 143-153
44. Ebadi M., Brown-Borg H., El Refaey H., Singh B.B., Garrett S., Shavali S., and Sharma S.K. Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease. Brain Res. Mol. Brain Res. 134 (2005) 67-75
45. Andrews G.K. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem. Pharmacol. 59 (2000) 95-104